Friday, 19 August 2022

 

 

LATEST NEWS To reach hospital for delivery, pregnant woman crosses river on rubber tube in MP Haryana CM approves preliminary report of Hathnikund dam Simona Halep withdraws from Western & Southern Open with leg injury Warwickshire sign pacer Mohammed Siraj for the last three matches of County Championship Taylor Swift's cameo request turned down by 'Twilight' director Indices erase losses, end marginally higher I feel I am a 'besura', says Lucky Ali, as he searches for the 8th 'sur': silence Angelina Jolie hires sons Maddox, Pax to work on her new film Priest sets himself on fire in Jaipur, admitted to hospital 'OG Khiladi' Akshay, 'new Anari' Emraan to have a dance off in 'Selfiee' Secrets Review: The PropheC Brings Out Another Soulful Track For The Fans Rohit Sharma in his quest for sustainability launched Limited Sustainable Collection with adidas India Mark Ruffalo calls Hulk an 'unwanted mentor' in She-Hulk's life Prabhas thumbs up for 'blockbuster success' of 'Karthikeya 2' It is a blessing in disguise if few quit the party: Ashok Gehlot Kamya Panjabi: I am very selfish as an actor and want to stand out Suspicious speed-boat found in Raigad, ATS to probe WhatsApp screenshot blocking now arrives on Android beta Tollywood actress Lakshmi Manchu makes it to 100 Most Beautiful Faces global list Hong Kong, Kuwait, Singapore, United Arab Emirates set to battle it out in Asia Cup qualifier NRIs in multi-crore drug case can't be extradited as Punjab cops hold back key info from Canada

 

Male contraceptive pills show promise in new study

Health, Study, New York, Research, Researchers, World News

Web Admin

Web Admin

5 Dariya News

New York , 12 Jun 2022

Two experimental male contraceptive pills appear to effectively lower testosterone without causing unacceptable side effects, says a new study.The drugs, called DMAU and 11 beta-MNTDC, are part of a class of drugs called progestogenic androgens. These drugs suppress testosterone, which lowers sperm count.

"Male contraception options are currently restricted to vasectomy and condoms, and are thus extremely limited as compared to female options," said lead researcher Tamar Jacobsohn of the Contraceptive Development Program at the Eunice Kennedy Shriver National Institute of Child Health and Human Development.

"Development of an effective, reversible male contraceptive method will improve reproductive options for men and women, have a major impact on public health by decreasing unintended pregnancy, and allow men to have an increasingly active role in family planning," Jacobsohn added.

For the study, to be presented at ENDO 2022, the team included 96 healthy male participants in two Phase 1 clinical trials. In each trial, the men were randomly assigned to receive two or four oral pills of active drug or placebo daily for 28 days.

After seven days on the active drug, testosterone levels dropped below the normal range. In men taking the placebo, testosterone levels stayed within the normal range.Lowering testosterone levels normally leads to unpleasant side effects, but most of the men in the study were willing to continue using the drugs, suggesting the side effects were acceptable.

The study found that 75 per cent of men who took the active drug said they would be willing to use it in the future, compared with 46.4 per cent of those taking a placebo.Men who took the four-pill daily dose (400 milligrams) had lower levels of testosterone than those taking the two-pill, 200-milligram dose.

There was no significant difference between the two active treatment groups in satisfaction with the drug, or willingness to use it in the future or recommend it to others.

 

Tags: Health , Study , New York , Research , Researchers , World News

 

 

related news

 

 

 

Photo Gallery

 

 

Video Gallery

 

 

5 Dariya News RNI Code: PUNMUL/2011/49000
© 2011-2022 | 5 Dariya News | All Rights Reserved
Powered by: CDS PVT LTD